Grimes & Company’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,392
| Closed | -$256K | – | 460 |
|
|
2026
Q1 | $256K | Buy |
3,392
+178
| +6% | +$13.4K | 0.01% | 384 |
|
|
2025
Q4 | $239K | Buy |
3,214
+38
| +1% | +$2.78K | 0.01% | 409 |
|
|
2025
Q3 | $214K | Sell |
3,176
-5
| -0.2% | -$332 | 0.01% | 432 |
|
|
2025
Q2 | $207K | Buy |
+3,181
| New | +$191K | 0.01% | 400 |
|
|
2025
Q1 | – | Sell |
-3,246
| Closed | -$234K | – | 385 |
|
|
2024
Q4 | $234K | Sell |
3,246
-17
| -0.5% | -$1.33K | 0.01% | 341 |
|
|
2024
Q3 | $266K | Buy |
3,263
+1
| +0% | +$80 | 0.01% | 313 |
|
|
2024
Q2 | $242K | Hold |
3,262
| – | – | 0.01% | 303 |
|
|
2024
Q1 | $254K | Sell |
3,262
-212
| -6% | -$15.8K | 0.01% | 289 |
|
|
2023
Q4 | $248K | Hold |
3,474
| – | – | 0.01% | 278 |
|
|
2023
Q3 | $241K | Hold |
3,474
| – | – | 0.01% | 257 |
|
|
2023
Q2 | $281K | Hold |
3,474
| – | – | 0.01% | 247 |
|
|
2023
Q1 | $280K | Hold |
3,474
| – | – | 0.01% | 246 |
|
|
2022
Q4 | $260K | Hold |
3,474
| – | – | 0.01% | 249 |
|
|
2022
Q3 | $224K | Hold |
3,474
| – | – | 0.01% | 247 |
|
|
2022
Q2 | $241K | Hold |
3,474
| – | – | 0.01% | 241 |
|
|
2022
Q1 | $267K | Sell |
3,474
-33
| -0.9% | -$2.37K | 0.01% | 250 |
|
|
2021
Q4 | $268K | Sell |
3,507
-36
| -1% | -$2.65K | 0.01% | 253 |
|
|
2021
Q3 | $262K | Hold |
3,543
| – | – | 0.01% | 253 |
|
|
2021
Q2 | $236K | Hold |
3,543
| – | – | 0.01% | 267 |
|
|
2021
Q1 | $264K | Buy |
3,543
+69
| +2% | +$5.24K | 0.01% | 237 |
|
|
2020
Q4 | $253K | Hold |
3,474
| – | – | 0.01% | 232 |
|
|
2020
Q3 | $231K | Buy |
+3,474
| New | +$220K | 0.01% | 228 |
|
Other funds holding HOLX
Grimes & Company's HOLX Position: Q2 2026 in Review
Grimes & Company sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,392 shares — an estimated $256K sold.
Grimes & Company first reported a position in HOLX in Q3 2020 and held it in 22 quarters. The position peaked at $281K in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Grimes & Company reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Grimes & Company sold 3,392 Hologic shares in Q2 2026, an estimated $256K.
- Grimes & Company first reported a position in Hologic in Q3 2020 and held it in 22 quarters.
- Grimes & Company's Hologic position peaked at $281K in Q2 2023.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.